Biotech Boom: Stocks Skyrocketing & What's Next Hosted by Laycee KluinMarch 5, 2024Add As Preferred SourceShareShareShare This VideoLink copied to clipboard. Play video for Biotech Boom: Stocks Skyrocketing & What's NextDetailsGuestsFrom the surging trend in weight loss megatrends to the innovative strides in smart chemotherapy, Dylan Jovine from Behind The Markets breaks down the shifts he's observed. We delve into the burgeoning weight loss market led by giants like Eli Lilly and Novo Nordisk, and the strategic acquisitions by big pharma to incorporate breakthrough weight loss drugs into their portfolios. Dylan also shares his golden rules for evaluating biotech stocks, emphasizing the importance of late-stage companies, strategic partnerships, and experienced management. Furthermore, we explore the emerging areas within biotech, notably the revolutionary smart chemo, and discuss the financial health and future prospects of biotech companies. Despite the risks and challenges facing the industry, including a shortfall in private funding, Dylan's insights provide valuable guidance for investors navigating this rapidly evolving sector.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioLLYEli Lilly and Company4.9094 of 5 stars$1,177.57+0.7%0.59%39.52NVONovo Nordisk A/S3.9237 of 5 stars$38.62+1.2%2.12%9.44IMGNImmunoGenN/A$31.23N/AN/AGSKGSK3.9704 of 5 stars$46.50-0.1%3.81%14.54BMYBristol Myers Squibb4.6728 of 5 stars$59.18-0.7%4.26%13.04IOVAIovance Biotherapeutics2.0796 of 5 stars$14.62+9.8%N/AN/A Compare These Stocks Add These Stocks to My Watchlist Laycee Kluin, HostDigital Marketing Strategist, MarketBeatPrevious VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube Listen to MarketBeat Other Platforms ChatGPT Changed Everything. This Is Even Bigger. (4 Stocks to Buy Now)MarketBeat TV | October 9, 2026Watch VideoRecent VideosAI Is Running Out of Power in the U.S. (Big Tech Is Betting Billions Somewhere Else)MarketBeat TV | October 8, 2026Watch VideoInstitutions Just Bought the Fear (4 Stocks to Buy Now)MarketBeat TV | October 7, 2026Watch VideoOnly 20 Stocks Are Holding Up the Market (3 Buy the Dip Stocks Outside of AI)MarketBeat TV | October 6, 2026Watch Video Featured Articles and OffersCould Nike’s Brutal Sell-Off Finally Be Running Out of Steam?October 4, 2026Do NOT Buy SpaceX – Do This InsteadFrom Stansberry Research (Ad)Want Private-Market Access to Kalshi and Polymarket? Try This ETFOctober 8, 2026NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can RunOctober 5, 2026DraftKings Stacks the Deck: The $800M Prediction PivotOctober 7, 2026Cigar Lake Flooded Again Uranium Supply Shock RepeatsFrom Digest Publishing (Ad) Search Headlines Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by Laycee KluinMarch 5, 2024Add As Preferred SourceShareShareShare This VideoLink copied to clipboard. Play video for Biotech Boom: Stocks Skyrocketing & What's NextDetailsGuestsFrom the surging trend in weight loss megatrends to the innovative strides in smart chemotherapy, Dylan Jovine from Behind The Markets breaks down the shifts he's observed. We delve into the burgeoning weight loss market led by giants like Eli Lilly and Novo Nordisk, and the strategic acquisitions by big pharma to incorporate breakthrough weight loss drugs into their portfolios. Dylan also shares his golden rules for evaluating biotech stocks, emphasizing the importance of late-stage companies, strategic partnerships, and experienced management. Furthermore, we explore the emerging areas within biotech, notably the revolutionary smart chemo, and discuss the financial health and future prospects of biotech companies. Despite the risks and challenges facing the industry, including a shortfall in private funding, Dylan's insights provide valuable guidance for investors navigating this rapidly evolving sector.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioLLYEli Lilly and Company4.9094 of 5 stars$1,177.57+0.7%0.59%39.52NVONovo Nordisk A/S3.9237 of 5 stars$38.62+1.2%2.12%9.44IMGNImmunoGenN/A$31.23N/AN/AGSKGSK3.9704 of 5 stars$46.50-0.1%3.81%14.54BMYBristol Myers Squibb4.6728 of 5 stars$59.18-0.7%4.26%13.04IOVAIovance Biotherapeutics2.0796 of 5 stars$14.62+9.8%N/AN/A Compare These Stocks Add These Stocks to My Watchlist Laycee Kluin, HostDigital Marketing Strategist, MarketBeatPrevious VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube
